Integrative Functional Genomics Analysis of Sustained Polyploidy Phenotypes in Breast Cancer Cells Identifies an Oncogenic Profile for GINS2

Aneuploidy is among the most obvious differences between normal and cancer cells. However, mechanisms contributing to development and maintenance of aneuploid cell growth are diverse and incompletely understood. Functional genomics analyses have shown that aneuploidy in cancer cells is correlated wi...

Full description

Bibliographic Details
Main Authors: Juha K. Rantala, Henrik Edgren, Laura Lehtinen, Maija Wolf, Kristine Kleivi, Hans Kristian Moen Vollan, Anna-Riina Aaltola, Petra Laasola, Sami Kilpinen, Petri Saviranta, Kristiina Iljin, Olli Kallioniemi
Format: Article
Language:English
Published: Elsevier 2010-11-01
Series:Neoplasia: An International Journal for Oncology Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558610800363
_version_ 1818808740268212224
author Juha K. Rantala
Henrik Edgren
Laura Lehtinen
Maija Wolf
Kristine Kleivi
Hans Kristian Moen Vollan
Anna-Riina Aaltola
Petra Laasola
Sami Kilpinen
Petri Saviranta
Kristiina Iljin
Olli Kallioniemi
author_facet Juha K. Rantala
Henrik Edgren
Laura Lehtinen
Maija Wolf
Kristine Kleivi
Hans Kristian Moen Vollan
Anna-Riina Aaltola
Petra Laasola
Sami Kilpinen
Petri Saviranta
Kristiina Iljin
Olli Kallioniemi
author_sort Juha K. Rantala
collection DOAJ
description Aneuploidy is among the most obvious differences between normal and cancer cells. However, mechanisms contributing to development and maintenance of aneuploid cell growth are diverse and incompletely understood. Functional genomics analyses have shown that aneuploidy in cancer cells is correlated with diffuse gene expression signatures and aneuploidy can arise by a variety of mechanisms, including cytokinesis failures, DNA endoreplication, and possibly through polyploid intermediate states. To identify molecular processes contributing to development of aneuploidy, we used a cell spot microarray technique to identify genes inducing polyploidy and/or allowing maintenance of polyploid cell growth in breast cancer cells. Of 5760 human genes screened, 177 were found to induce severe DNA content alterations on prolonged transient silencing. Association with response to DNA damage stimulus and DNA repair was found to be the most enriched cellular processes among the candidate genes. Functional validation analysis of these genes highlighted GINS2 as the highest ranking candidate inducing polyploidy, accumulation of endogenous DNA damage, and impairing cell proliferation on inhibition. The cell growth inhibition and induction of polyploidy by suppression of GINS2 was verified in a panel of breast cancer cell lines. Bioinformatic analysis of published gene expression and DNA copy number studies of clinical breast tumors suggested GINS2 to be associated with the aggressive characteristics of a subgroup of breast cancers in vivo. In addition, nuclear GINS2 protein levels distinguished actively proliferating cancer cells suggesting potential use of GINS2 staining as a biomarker of cell proliferation as well as a potential therapeutic target.
first_indexed 2024-12-18T19:46:22Z
format Article
id doaj.art-6f6d90d7e02a40de9e1ca47441b9ead5
institution Directory Open Access Journal
issn 1476-5586
1522-8002
language English
last_indexed 2024-12-18T19:46:22Z
publishDate 2010-11-01
publisher Elsevier
record_format Article
series Neoplasia: An International Journal for Oncology Research
spelling doaj.art-6f6d90d7e02a40de9e1ca47441b9ead52022-12-21T20:55:18ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55861522-80022010-11-01121187788810.1593/neo.10548Integrative Functional Genomics Analysis of Sustained Polyploidy Phenotypes in Breast Cancer Cells Identifies an Oncogenic Profile for GINS2Juha K. Rantala0Henrik Edgren1Laura Lehtinen2Maija Wolf3Kristine Kleivi4Hans Kristian Moen Vollan5Anna-Riina Aaltola6Petra Laasola7Sami Kilpinen8Petri Saviranta9Kristiina Iljin10Olli Kallioniemi11Medical Biotechnology, VTT Technical Research Centre of Finland, Turku, FinlandInstitute for Molecular Medicine Finland (FIMM), Biomedicum 2U, University of Helsinki, Helsinki, FinlandMedical Biotechnology, VTT Technical Research Centre of Finland, Turku, FinlandInstitute for Molecular Medicine Finland (FIMM), Biomedicum 2U, University of Helsinki, Helsinki, FinlandMedical Biotechnology, VTT Technical Research Centre of Finland, Turku, FinlandDepartment of Genetics, Institute for Cancer Research, Oslo University Hospital - Radiumhospitalet, Oslo, NorwayMedical Biotechnology, VTT Technical Research Centre of Finland, Turku, FinlandMedical Biotechnology, VTT Technical Research Centre of Finland, Turku, FinlandInstitute for Molecular Medicine Finland (FIMM), Biomedicum 2U, University of Helsinki, Helsinki, FinlandMedical Biotechnology, VTT Technical Research Centre of Finland, Turku, FinlandMedical Biotechnology, VTT Technical Research Centre of Finland, Turku, FinlandMedical Biotechnology, VTT Technical Research Centre of Finland, Turku, FinlandAneuploidy is among the most obvious differences between normal and cancer cells. However, mechanisms contributing to development and maintenance of aneuploid cell growth are diverse and incompletely understood. Functional genomics analyses have shown that aneuploidy in cancer cells is correlated with diffuse gene expression signatures and aneuploidy can arise by a variety of mechanisms, including cytokinesis failures, DNA endoreplication, and possibly through polyploid intermediate states. To identify molecular processes contributing to development of aneuploidy, we used a cell spot microarray technique to identify genes inducing polyploidy and/or allowing maintenance of polyploid cell growth in breast cancer cells. Of 5760 human genes screened, 177 were found to induce severe DNA content alterations on prolonged transient silencing. Association with response to DNA damage stimulus and DNA repair was found to be the most enriched cellular processes among the candidate genes. Functional validation analysis of these genes highlighted GINS2 as the highest ranking candidate inducing polyploidy, accumulation of endogenous DNA damage, and impairing cell proliferation on inhibition. The cell growth inhibition and induction of polyploidy by suppression of GINS2 was verified in a panel of breast cancer cell lines. Bioinformatic analysis of published gene expression and DNA copy number studies of clinical breast tumors suggested GINS2 to be associated with the aggressive characteristics of a subgroup of breast cancers in vivo. In addition, nuclear GINS2 protein levels distinguished actively proliferating cancer cells suggesting potential use of GINS2 staining as a biomarker of cell proliferation as well as a potential therapeutic target.http://www.sciencedirect.com/science/article/pii/S1476558610800363
spellingShingle Juha K. Rantala
Henrik Edgren
Laura Lehtinen
Maija Wolf
Kristine Kleivi
Hans Kristian Moen Vollan
Anna-Riina Aaltola
Petra Laasola
Sami Kilpinen
Petri Saviranta
Kristiina Iljin
Olli Kallioniemi
Integrative Functional Genomics Analysis of Sustained Polyploidy Phenotypes in Breast Cancer Cells Identifies an Oncogenic Profile for GINS2
Neoplasia: An International Journal for Oncology Research
title Integrative Functional Genomics Analysis of Sustained Polyploidy Phenotypes in Breast Cancer Cells Identifies an Oncogenic Profile for GINS2
title_full Integrative Functional Genomics Analysis of Sustained Polyploidy Phenotypes in Breast Cancer Cells Identifies an Oncogenic Profile for GINS2
title_fullStr Integrative Functional Genomics Analysis of Sustained Polyploidy Phenotypes in Breast Cancer Cells Identifies an Oncogenic Profile for GINS2
title_full_unstemmed Integrative Functional Genomics Analysis of Sustained Polyploidy Phenotypes in Breast Cancer Cells Identifies an Oncogenic Profile for GINS2
title_short Integrative Functional Genomics Analysis of Sustained Polyploidy Phenotypes in Breast Cancer Cells Identifies an Oncogenic Profile for GINS2
title_sort integrative functional genomics analysis of sustained polyploidy phenotypes in breast cancer cells identifies an oncogenic profile for gins2
url http://www.sciencedirect.com/science/article/pii/S1476558610800363
work_keys_str_mv AT juhakrantala integrativefunctionalgenomicsanalysisofsustainedpolyploidyphenotypesinbreastcancercellsidentifiesanoncogenicprofileforgins2
AT henrikedgren integrativefunctionalgenomicsanalysisofsustainedpolyploidyphenotypesinbreastcancercellsidentifiesanoncogenicprofileforgins2
AT lauralehtinen integrativefunctionalgenomicsanalysisofsustainedpolyploidyphenotypesinbreastcancercellsidentifiesanoncogenicprofileforgins2
AT maijawolf integrativefunctionalgenomicsanalysisofsustainedpolyploidyphenotypesinbreastcancercellsidentifiesanoncogenicprofileforgins2
AT kristinekleivi integrativefunctionalgenomicsanalysisofsustainedpolyploidyphenotypesinbreastcancercellsidentifiesanoncogenicprofileforgins2
AT hanskristianmoenvollan integrativefunctionalgenomicsanalysisofsustainedpolyploidyphenotypesinbreastcancercellsidentifiesanoncogenicprofileforgins2
AT annariinaaaltola integrativefunctionalgenomicsanalysisofsustainedpolyploidyphenotypesinbreastcancercellsidentifiesanoncogenicprofileforgins2
AT petralaasola integrativefunctionalgenomicsanalysisofsustainedpolyploidyphenotypesinbreastcancercellsidentifiesanoncogenicprofileforgins2
AT samikilpinen integrativefunctionalgenomicsanalysisofsustainedpolyploidyphenotypesinbreastcancercellsidentifiesanoncogenicprofileforgins2
AT petrisaviranta integrativefunctionalgenomicsanalysisofsustainedpolyploidyphenotypesinbreastcancercellsidentifiesanoncogenicprofileforgins2
AT kristiinailjin integrativefunctionalgenomicsanalysisofsustainedpolyploidyphenotypesinbreastcancercellsidentifiesanoncogenicprofileforgins2
AT ollikallioniemi integrativefunctionalgenomicsanalysisofsustainedpolyploidyphenotypesinbreastcancercellsidentifiesanoncogenicprofileforgins2